Deferred direct-acting antiviral treatment in kidney transplantation from HCV-viremic donors into HCV-negative recipients

被引:0
|
作者
Pagano, Giulia [1 ]
Sola, Eulalia [2 ]
Canete, Nuria [1 ,3 ]
Broquetas, Teresa [1 ,3 ]
Carrion, Jose A. [1 ,4 ]
Puigvehi, Marc [1 ,3 ]
Coll, Susanna [1 ,3 ]
Garrido, Esther [1 ,3 ]
Viu, Ana [3 ]
Romero, Judit [1 ]
Jose Perez, Maria [2 ]
Zapatero, Ana [5 ]
Bessa, Xavier [1 ,3 ]
Crespo Barrio, Marta [2 ]
Garcia-Retortillo, Montserrat [1 ,3 ]
机构
[1] Hosp del Mar, Liver Sect, Dept Gastroenterol, Barcelona, Spain
[2] Hosp del Mar, Dept Nephrol, Barcelona, Spain
[3] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain
[4] Univ Autonoma Barcelona, Bellaterra, Spain
[5] Hosp del Mar, Transplant Coordinat, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PO-2021
引用
收藏
页码:S799 / S799
页数:1
相关论文
共 50 条
  • [1] A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients
    Daloul, Reem
    Pesavento, Todd E.
    Goldberg, David S.
    Reese, Peter P.
    KIDNEY INTERNATIONAL, 2021, 100 (06) : 1190 - 1198
  • [2] Geographic Variation in the Utilization of HCV-viremic Donors into HCV-negative Recipients
    Bekki, Yuki
    Myers, Bryan
    TRANSPLANTATION, 2022, 106 (02) : E165 - E165
  • [3] SUCCESSFUL EARLY SOFOSBUVIR-BASED ANTIVIRAL TREATMENT AFTER TRANSPLANTATION OF KIDNEYS FROM HCV-VIREMIC DONORS INTO HCV-NEGATIVE RECIPIENTS
    Friebus-Kardash, Justa
    Gaeckler, Anja
    Kribben, Andreas
    Witzke, Oliver
    Wedemeyer, Heiner
    Treckmann, Juergen
    Herzer, Kerstin
    Eisenberger, Ute
    TRANSPLANT INTERNATIONAL, 2019, 32 : 203 - 203
  • [4] Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients
    Friebus-Kardash, Justa
    Gaeckler, Anja
    Kribben, Andreas
    Witzke, Oliver
    Wedemeyer, Heiner
    Treckmann, Juergen
    Herzer, Kerstin
    Eisenberger, Ute
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (05)
  • [5] Efficacy and Safety of Direct-Acting Antivirals in Kidney Transplantation From HCV-Viremic Donors to Negative Recipients: A Meta-Analysis
    Feng, Zepei
    Zhang, Jinwei
    Tan, Weilong
    Wang, Chunhui
    Chen, Qiong
    Shen, Chao
    Fan, Haozhi
    Zhang, Yun
    Huang, Peng
    Yue, Ming
    FRONTIERS IN MEDICINE, 2022, 9
  • [6] Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
    Kapila, Nikhil
    Al Khalloufi, Kawtar
    Flocco, Gianina
    Menon, K. V. Narayanan
    Lindenmeyer, Christina
    Reino, Diego
    Vanatta, Jason M.
    Ebaid, Samer
    Tzakis, Andreas
    Zervos, Xaralambos Bobby
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (02) : 122 - 126
  • [7] The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients
    Cotter, Thomas G.
    Charlton, Michael
    TRANSPLANTATION, 2022, 106 (02) : E166 - E166
  • [8] Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era
    Kapila, Nikhil
    Al-Khalloufi, Kawtar
    Bejarano, Pablo A.
    Vanatta, Jason M.
    Zervos, Xaralambos B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (02) : 600 - 605
  • [9] Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation
    Cotter, Thomas G.
    Aronsohn, Andrew
    Reddy, K. Gautham
    Charlton, Michael
    TRANSPLANTATION, 2021, 105 (06) : 1285 - 1290
  • [10] Transplantation of kidneys from HCV viremic donors to HCV viremic recipients followed by early direct acting antiviral therapy without ribavirin
    Kapila, Nikhil
    Flocco, Gianina
    Al Khalloufi, Kawtar
    Zervos, Xaralambos B.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (03) : 407 - 409